Catalog No.
KDD68902
Detection method
Colorimetric
Sample type
Plasma, Serum
Assay type
Quantitative
Range
78.125 - 5,000 ng/mL
Sensitivity
33.12 ng/mL
Precision
CV<20%
Recovery
80-120%
Shipping
2-8 ℃
Stability and Storage
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Alternative Names
CAS: 1453067-91-8
Costimulation blockade: the next generation., PMID:39882641
New Developments and Therapeutic Drug Monitoring Options in Costimulatory Blockade in Solid Organ Transplantation: A Systematic Critical Review., PMID:39570574
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study., PMID:39042770
Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab., PMID:38657446
Comparative Safety and Efficacy of Immunosuppressive Regimens Post-kidney Transplant: A Systematic Review., PMID:37746361
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials., PMID:34963678
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study., PMID:31509331
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation., PMID:31397943
Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis., PMID:29679478
Costimulation Blockade in Kidney Transplantation: An Update., PMID:27472094
Current status of costimulatory blockade in renal transplantation., PMID:27517137
Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys., PMID:24992357
Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects., PMID:24731050
Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys., PMID:24389907
Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates., PMID:22420525